Rosuvastatin 10mg ( DrugBank: Rosuvastatin )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 97 | Ulcerative colitis | 1 |
97. Ulcerative colitis
Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04883840 (ClinicalTrials.gov) | October 22, 2020 | 6/5/2021 | Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis | Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis | Ulcerative Colitis | Drug: Rosuvastatin 10mg | Universitaire Ziekenhuizen KU Leuven | Vlaams Instituut Biotechnologie (VIB) | Recruiting | 18 Years | 70 Years | All | 220 | Phase 2/Phase 3 | Belgium |